Nyla A. Heerema

Nyla A. Heerema's research focuses on childhood and young adult acute lymphoblastic leukemia (ALL), a cancer of white blood cells, with particular attention to genetic subtypes, relapse, and treatment outcomes. Much of this work is conducted through the Children's Oncology Group, a large multi-institutional clinical trials network, examining factors like disease genetics, minimal residual disease (leftover cancer cells after treatment), central nervous system involvement, and disparities in outcomes by race, ethnicity, and socioeconomic status. This research contributes to large-scale clinical trials and observational studies aimed at improving survival and treatment strategies for pediatric blood cancers.

Publication output has fluctuated over the past decade, with a notable peak in 2023 followed by a decline in 2024-2025, though the underlying data may include some non-standard entries (e.g., supplementary data records).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026